Related Experiment Video
Updated: Jul 4, 2026
07:57
Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
Diabetic dyslipidemia: a practical guide to therapy.
John M Tovar1, Oralia V Bazaldua, Alexandra Loffredo
1Feik School of Pharmacy, University of the Incarnate Word San Antonio, TX USA. jmtovar@uiwtx.edu
The Journal of Family Practice
|June 12, 2008
Summary
For diabetic patients, lowering low-density lipoprotein (LDL) is key. While statins are preferred for LDL reduction, evidence for a specific LDL goal remains limited.
Area of Science:
- Cardiology
- Endocrinology
- Pharmacology
Background:
- Diabetes mellitus frequently presents with dyslipidemia, characterized by elevated triglycerides (TG) and low high-density lipoprotein (HDL) cholesterol.
- Low-density lipoprotein (LDL) cholesterol is a primary therapeutic target in patients with diabetes due to increased cardiovascular risk.
Purpose of the Study:
- To evaluate the role of lipid-lowering therapies in patients with diabetes.
- To assess the evidence supporting a specific LDL cholesterol goal for diabetic individuals.
Main Methods:
- Review of current clinical guidelines and supporting data for lipid-lowering therapies in diabetes.
- Analysis of the efficacy of statins, fibrates, and niacin in managing dyslipidemia in diabetic patients.
Main Results:
- Statins are the primary agents for reducing LDL cholesterol in diabetic patients.
- Combination therapy with fibrates or niacin is often used for concurrent TG and HDL abnormalities.
- Current data supporting a stringent LDL goal (<70 mg/dL) in diabetes is limited and conflicting.
Conclusions:
- LDL cholesterol remains the primary target for lipid-lowering therapy in patients with diabetes.
- While statins are effective for LDL reduction, the optimal LDL target requires further investigation.
- Management of TG and HDL levels is also crucial in this patient population.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:18Lipids: Dietary Sources and Requirements
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...